Jason Apter
Directeur Général chez Sannova Analytical, Inc.
Profil
Jason Apter is currently the Chief Executive Officer at Sannova Analytical, Inc. since 2022.
Prior to this, he worked as the Chief Executive-Health Sector at Johnson Matthey Plc from 2018 to 2020.
Postes actifs de Jason Apter
| Sociétés | Poste | Début |
|---|---|---|
Sannova Analytical, Inc.
 Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Directeur Général | 26/10/2022 |
Anciens postes connus de Jason Apter
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON MATTHEY PLC | Corporate Officer/Principal | 01/06/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON MATTHEY PLC | Process Industries |
| Entreprise privées | 1 |
|---|---|
Sannova Analytical, Inc.
Sannova Analytical, Inc. Miscellaneous Commercial ServicesCommercial Services Sannova Analytical, Inc. is a contract research organization that provides bioanalytical and chemistry manufacturing and controls testing services to biopharmaceutical and biotech companies for both small and large molecules. The company is based in Somerset, NJ and was founded in 2006 by Venkat Reddy, Geeta Vidiyala, and Malleswar Kollu. Sannova is known for its consistently low variability data, quick turnaround times, and over 300 validated methods. The company has completed over 1,200 clinical trials and has maintained an impeccable inspection record with the FDA and its sponsors. Sannova is considered a trusted and quality-focused partner in drug development by customers with a strong track record of regulatory compliance. Jason Apter has been the CEO of the company since 2022. | Commercial Services |
